Double Umbilical Cord Blood Transplantation: A Study of Early Engraftment Kinetics in Leukocyte Subsets using HLA-Specific Monoclonal Antibodies

Biology of Blood and Marrow Transplantation

Volumn 19, Issue 2, 2013, Pages 266-273

  Somers, Judith A E ^a,b   Brand, Anneke ^a,c   van Hensbergen, Yvette ^a   Mulder, Arend ^d   Oudshoorn, Machteld ^c,d   Sintnicolaas, Kees ^a   Gratama, Jan Willem ^b   Falkenburg, J H Frederik ^d   Braakman, Eric ^b   Cornelissen, Jan J ^b  

^a CENTRAL LABORATORY   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c Europdonor Foundation   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Chimerism; Cord blood unit predominance; Double umbilical cord blood transplantation; Engraftment kinetics; HLA specific monoclonal antibodies

Indexed keywords

HLA A ANTIGEN; HLA ANTIBODY; HLA B ANTIGEN; MONOCLONAL ANTIBODY;

ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ANTIGEN SPECIFICITY; APLASTIC ANEMIA; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CELL KINETICS; CELL SUBPOPULATION; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CORD BLOOD STEM CELL TRANSPLANTATION; DOUBLE UMBILICAL CORD BLOOD TRANSPLANTATION; ENGRAFTMENT; FLOW CYTOMETRY; GRAFT RECIPIENT; HLA MATCHING; HUMAN; HUMAN CELL; INVERSE POLYMERASE CHAIN REACTION; LEUKOCYTE; LEUKOCYTE TRANSFUSION; NATURAL KILLER CELL; POLYMERASE CHAIN REACTION; REDUCED INTENSITY CONDITIONING; SHORT TANDEM REPEAT; UMBILICAL CORD BLOOD;

ADULT; ANTIBODIES, MONOCLONAL; CHIMERISM; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; GRAFT SURVIVAL; HEMATOLOGIC NEOPLASMS; HLA-A ANTIGENS; HLA-B ANTIGENS; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84872621323     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2012.09.022     Document Type: Article

References (39)

1. Laughlin M.J., Eapen M., Rubinstein P., et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukaemia. N Engl J Med 2004, 351:2265-2275.
2. Rocha V., Labopin M., Sanz G., et al. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med 2004, 351:2276-2285.
3. Barker J.N., Weisdorf D.J., DeFor T.E., et al. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 2005, 105:1343-1347.
4. Barker J.N., Weisdorf D.J., DeFor T.E., et al. Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. Blood 2003, 102:1915-1919.
5. Ballen K.K., Spitzer T.R., Yeap B.Y., et al. Double unrelated reduced-intensity umbilical cord blood transplantation in adults. Biol Blood Marrow Transplant 2007, 13:82-89.
6. Brunstein C.G., Barker J.N., Weisdorf D.J., et al. Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease. Blood 2007, 110:3064-3070.
7. Verneris M.R., Brunstein C.G., Barker J.N., et al. Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units. Blood 2009, 114:4293-4299.
8. Kang H.J., Kho S.H., Jang M.K., et al. Early engraftment kinetics of two units cord blood transplantation. Bone Marrow Transplant 2006, 38:197-201.
9. Zhou M., Sun Z., Liu H., et al. Engraftment kinetics after transplantation of double units of umbilical cord blood from unrelated donors in adolescents and adults with hematologic malignancies. Blood 2009, 114. (abstract 1183).
10. Thiede C., Bomhäuser M., Oelschlägel U., et al. Sequential monitoring of chimerism and detection of minimal residual disease after allogeneic blood stem cell transplantation (BSCT) using multiplex PCR amplification of short tandem repeat-markers. Leukemia 2001, 15:293-302.
11. Mulder A., Kardol M.J., Arn J.S., et al. Human monoclonal HLA antibodies reveal interspecies cross reactive swine MHC class I epitopes relevant for xenotransplantation. Mol Immunol 2010, 47:809-815.
12. van Hensbergen Y., Mulder A., Cornelissen J., Brand A. Validation of human monoclonal HLA class I antibodies to evaluate the kinetics of donor chimerism in different cell subsets after double-cord-blood transplantation in the NOD/SCID model. Transfusion 2012 May 3, [Epub ahead of print]. 10.1111/j.1537-2995.2012.03678.x.
13. Clinical and Laboratory Standards Institute (CLSI). Enumeration of immunologically defined cell populations by flow cytometry; approved guideline-second edition. CLSI document H42-A2. Clinical and Laboratory Standards Institute, Wayne, Pennsylvania 19087-1898 USA, 2007.
14. Avery S., Shi W., Lubin M., et al. Influence of infused cell dose and HLA match on engraftment after double-unit cord blood allografts. Blood 2011, 117:3277-3285.
15. Delaney C., Gutman J.A., Appelbaum F.R. Cord blood transplantation for haematological malignancies: conditioning regimens, double cord blood transplant and infectious complications. Br J Haematol 2009, 147:207-216.
16. Majhail N.S., Brunstein C.G., Wagner J.E. Double umbilical cord blood transplantation. Curr Opin Immunol 2006, 18:571-575.
17. Scaradavou A., Smith K.M., Hawke R., et al. Cord blood units with low CD34+ cell viability have a low probability of engraftment after double unit transplantation. Biol Blood Marrow Transplant 2010, 16:500-508.
18. Page K.M., Gentry T., Shoulars K., et al. Use of aldehyde dehydrogenase content to predict dominating cord in double cord blood transplant. Blood 2009, 114:2155.
19. Ramirez P., Wagner J.E., deFor T., et al. Factors predicting single-unit predominance after double umbilical cord blood transplantation. Bone Marrow Transplant 2012, 47:799-803.
20. Gutman J.A., Turtle C.J., Manley T.J., et al. Single-unit dominance after double-unit umbilical cord blood transplantation coincides with a specific CD8+ T-cell response against the nonengrafted unit. Blood 2010, 115:757-765.
21. Moretta A., Andriolo G., Lisini D., et al. In vitro evaluation of graft-versus-graft alloreactivity as a tool to identify the predominant cord blood unit before double cord blood transplantation. Biol Blood Marrow Transplant 2012, 18:1108-1118.
22. Berglund S., Okas M., Gertow J., et al. Stable mixed-donor chimerism after double cord blood transplantation. Int J Haematol 2009, 90:526-531.
23. Newell L.F., Milano F., Nicoud S., et al. Early CD3 peripheral blood chimerism predicts the long-term engrafting unit following myeloablative double-cord blood transplantation. Biol Blood Marrow Transplant 2012 Aug, 18:1243-1249.
24. Chiesa R., Gilmour K., Qasim W., et al. Omission of in vivo T-cell depletion promotes rapid expansion of naive CD4(+) cord blood lymphocytes and restores adaptive immunity within 2 months after unrelated cord blood transplant. Br J Haematol 2012, 156:656-666.
25. Flake A.W., Zanjani E.D. In utero hematopoietic stem cell transplantation. A status report. JAMA 1997, 278:932-937.
26. Muench M.O. In utero transplantation: baby steps towards an effective therapy. Bone Marrow Transplant 2005, 35:537-547.
27. Cohen G., Carter S.L., Weinberg K.I., et al. Antigen-specific T-lymphocyte function after cord blood transplantation. Biol Blood Marrow Transplant 2006, 12:1335-1342.
28. Rutten C.E., van Luxemburg-Heijs S.A.P., Griffioen M., et al. HLA-DP as specific target for cellular immunotherapy in HLA class II-expressing B-cell leukemia. Leukemia 2008, 22:1387-1394.
29. Rutten C.E., van Luxemburg-Heijs S.A.P., van der Meijden E.D., et al. Both permissive and nonpermissive HLA-DPB1 mismatches can induce polyclonal HLA-DPB1 specific immune responses in vivo and in vitro. Blood 2010, 115:151-153.
30. Renard C., Barlogis V., Mialou V., et al. Lymphocyte subset reconstitution after unrelated cord blood or bone marrow transplantation in children. Br J Haematol 2010, 152:322-330.
31. Beziat V., Nguyen S., Lapusan S., et al. Fully functional NK cells after unrelated cord blood transplantation. Leukemia 2009, 23:721-728.
32. Tarek N., Gallagher M.M., Chou J.F., et al. KIR-HLA genotypes have no identifiable role in unit predominance following double unit cord blood transplantation. Biol Blood Marrow Transplant 2011, 17(suppl):S286-S287.
33. McSweeney P.A., Niederwieser D., Shizuru J.A., et al. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood 2001, 97:3390-3400.
34. Niederwieser D., Maris M., Shizuru J.A., et al. Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases. Blood 2003, 101:1620-1629.
35. Sorror M.L., Maris M.B., Storer B., et al. Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation morbidities. Blood 2004, 104:961-968.
36. Miyakoshi S., Yuji K., Masahino K., et al. Successful engraftment after reduced-intensity umbilical cord blood transplantation for adult patients with advanced hematological diseases. Clin Cancer Res 2004, 10:3586-3592.
37. Misawa M., Kai S., Okada M., et al. Reduced-intensity conditioning followed by unrelated umbilical cord blood transplantation for advanced hematologic malignancies: rapid engraftment in bone marrow. Int J Hematol 2006, 83:74-79.
38. Brunstein C.G., Eapen M., Ahn K.W., et al. Reduced intensity conditioning transplantation in acute leukemia: the effect of source of unrelated donor stem cells on outcomes. Blood 2012, 119:5591-5598.
39. Voogt P.J., Fibbe W.E., Veenhof W.F.J., et al. Cell-mediated lysis of human hematopoietic progenitor cells. Leukemia 1987, 1:427-431.